This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Philpott, A. Articles by Anderson, T. J. Search for Related Content PubMed PubMed Citation Articles by Philpott, A. Articles by Anderson, T. J. Related Collections Related Article

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2007;27:2065.)
© 2007 American Heart Association, Inc.

Editorial

Reactive Hyperemia and Cardiovascular Risk

Andrew Philpott; Todd J. Anderson

From the Department of Cardiovascular Sciences and the Libin Cardiovascular Institute, University of Calgary, Alberta, Canada.

Correspondence to T.J. Anderson, MD, 1403 29th Street NW, Calgary, AB, T2N 2T9. E-mail todd.anderson@calgaryhealthregion.ca

Key Words: atherosclerosis • endothelial function • risk factor • microvessels

An extract of the first 250 words of the full text is provided, because this article has no abstract.

	Introduction

 
Since the description of the classical cardiovascular risk factors by the Framingham group some 50 years ago,¹ more recent efforts have explored the utility of biomarkers to further refine risk stratification. Although vascular imaging and biochemical markers have shown considerable promise,² assessment of vascular function has particular appeal. Endothelial dysfunction is an attendant feature of established atherosclerosis³ and a precursor when only risk factors for atherosclerosis are present.⁴ It is thought in large part to reflect decreased nitric oxide bioavailability in the vasculature. As such it has been suggested that endothelial dysfunction plays a central pathophysiological role in the development and clinical expression of cardiovascular disease, making it well suited as a surrogate marker of risk.

See p 2113

	Assessment of Endothelial Function

 
Endothelial function has been generally assessed by measuring vasomotion of conduit vessels or regional increases in blood flow, reflecting microvascular/resistance vessel function, in the coronary or peripheral circulation. Although coronary endothelial function remains a "gold standard," its complexity and invasive requirements do not permit extensive use. Flow-mediated dilation of the peripheral circulation (FMD) has evolved as a popular marker because of the relative simplicity, a belief that it largely reflects nitric oxide–dependent endothelial function, its correlation with coronary reactivity, and modulation by risk factors or their treatment. What is often underappreciated, however, is that the relationship between vascular risk factors and FMD is rather poor. In addition, the correlation between measures of conduit vessel and microvascular function is weak and ultimately it is microvascular function that controls blood flow and oxygen . . . [Full Text of this Article]

Related Article:

Predictive Value of Reactive Hyperemia for Cardiovascular Events in Patients With Peripheral Arterial Disease Undergoing Vascular Surgery

Alex L. Huang, Annemarie E. Silver, Elena Shvenke, David W. Schopfer, Eiman Jahangir, Megan A. Titas, Alex Shpilman, James O. Menzoian, Michael T. Watkins, Joseph D. Raffetto, Gary Gibbons, Jonathan Woodson, Palma M. Shaw, Mandeep Dhadly, Robert T. Eberhardt, John F. Keaney, Jr, Noyan Gokce, and Joseph A. Vita
Arterioscler Thromb Vasc Biol 2007 27: 2113-2119. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

				M. M. McDermott, P. Ades, J. M. Guralnik, A. Dyer, L. Ferrucci, K. Liu, M. Nelson, D. Lloyd-Jones, L. Van Horn, D. Garside, et al. Treadmill Exercise and Resistance Training in Patients With Peripheral Arterial Disease With and Without Intermittent Claudication: A Randomized Controlled Trial JAMA, January 14, 2009; 301(2): 165 - 174. [Abstract] [Full Text] [PDF]

				B. Galarraga, F. Khan, P. Kumar, T. Pullar, and J. J. F. Belch C-reactive protein: the underlying cause of microvascular dysfunction in rheumatoid arthritis Rheumatology, December 1, 2008; 47(12): 1780 - 1784. [Abstract] [Full Text] [PDF]